+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Sorting Market - Global Forecast 2026-2032- Product Image
Cell Sorting Market - Global Forecast 2026-2032- Product Image
Sale

Cell Sorting Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010768
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell Sorting Market is projected to reach USD 1.85 Billion in 2026. It is expected to continue growing at a CAGR of 8.79%, reaching USD 3.07 Billion by 2032.

The cell sorting market is moving from a specialized laboratory workflow to a strategic enabler of precision medicine, immuno-oncology, stem cell research, infectious disease surveillance, and biomanufacturing. Demand is being led by fluorescence-activated cell sorting (FACS), magnetic-activated cell sorting (MACS), microfluidic cell sorting, and emerging label-free platforms that help researchers isolate viable cell populations with higher purity, throughput, and reproducibility.

Growth is supported by measurable expansion in cell and gene therapy pipelines, wider use of single-cell analysis, and sustained public funding for biomedical research through agencies such as the NIH, the European Commission, and national science foundations. As laboratories seek faster turnaround, lower sample loss, and compliant data handling, vendors are competing on automation, closed-system processing, biosafety, software intelligence, and service reliability.

Transformative Shifts in the Cell Sorting Landscape

The cell sorting landscape is being reshaped by the shift from manual, operator-dependent processes toward automated, standardized, and data-rich workflows. High-parameter flow cytometry, spectral cytometry, cartridge-based microfluidics, imaging-enabled sorting, and sterile closed systems are changing how academic centers, contract research organizations, diagnostics developers, and biopharmaceutical manufacturers process rare and sensitive cells.

A second structural shift is the movement of cell sorting from discovery research into translational and GMP-adjacent environments. This raises requirements for traceability, sterility assurance, calibration, sample viability, biosafety, and regulatory documentation, especially where sorted cells are used in CAR-T development, regenerative medicine, immunophenotyping, and companion diagnostic research.

Cumulative Impact of Artificial Intelligence in Cell Sorting

Artificial intelligence is becoming a cumulative force across cell sorting by improving gating, anomaly detection, event classification, experiment design, and instrument maintenance. AI-assisted flow cytometry analysis can reduce inter-operator variability in data interpretation, a persistent challenge in high-dimensional immunophenotyping, rare-cell identification, and longitudinal immune monitoring.

The strongest impact is emerging where AI is integrated with spectral cytometry, imaging flow cytometry, and single-cell multi-omics. These systems generate complex datasets that benefit from machine learning models capable of identifying subtle phenotypes, accelerating target validation, improving quality control, and supporting more consistent decision-making in clinical research and bioprocess development.

Key Regional Insights

Asia-Pacific is expanding rapidly as China, India, Japan, Australia, and South Korea invest in biotechnology, cancer research, vaccine platforms, and advanced therapy manufacturing. China’s biopharma ecosystem and hospital-linked research networks support demand for high-throughput flow cytometry and magnetic cell sorting, while India benefits from a growing clinical research base, public biotechnology initiatives, and lower-cost life science services. Japan, Australia, and South Korea contribute through strong academic research, regenerative medicine programs, precision oncology initiatives, and biologics manufacturing capabilities.

North America remains the most mature region due to the United States’ large NIH-funded research base, extensive biopharmaceutical R&D, strong clinical trial activity, and early adoption of cell therapy workflows, while Canada supports demand through immunology, oncology, and stem cell research clusters. Europe benefits from European Union research programs, advanced academic hospitals, and established life science manufacturing in Germany, France, the United Kingdom, Italy, and Spain, supported by strong regulatory emphasis on quality and traceability. Latin America, led by Brazil and Mexico, is developing through public health research, academic laboratories, infectious disease monitoring, and private diagnostics investment. The Middle East, particularly GCC countries, is building biomedical infrastructure through national healthcare transformation plans, genomics programs, and cancer care modernization, while Africa’s opportunity is linked to infectious disease research, capacity building, workforce training, and regional laboratory modernization.

Key Group Insights

ASEAN demand is supported by expanding biomedical research capacity in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, with Singapore serving as a regional hub for biopharma R&D, translational medicine, and clinical research. The GCC is investing in precision medicine, cancer care, genomics, hospital modernization, and specialized laboratory infrastructure, creating selective opportunities for advanced flow cytometry, magnetic separation, and closed cell processing systems.

The European Union provides a strong regulatory, research, and funding environment for collaborative science, workflow standardization, advanced therapy development, and cross-border biomedical innovation. BRICS countries represent a high-volume growth base because Brazil, Russia, India, China, and South Africa combine large patient populations with expanding biomedical infrastructure, public health priorities, and rising biotechnology capabilities. G7 markets continue to lead in innovation, instrument adoption, clinical translation, and high-complexity research workflows, while NATO member countries reinforce demand through biomedical defense, infectious disease preparedness, biosecurity research, and resilient laboratory infrastructure.

Key Country Insights

The United States leads global adoption through deep biopharma investment, NIH-backed immunology and oncology research, strong clinical trial activity, and a dense network of academic medical centers using FACS, MACS, spectral cytometry, and single-cell analysis. Canada shows strength in stem cell science, immunology, and translational medicine, while Mexico is gaining traction through clinical laboratories, academic research, diagnostics expansion, and proximity to North American life science supply chains. Brazil anchors Latin American demand through oncology, infectious disease, vaccine research, and public research institutions.

In Europe, the United Kingdom remains influential in genomics, cell therapy trials, and academic-industry collaboration; Germany combines engineering strength with bioprocessing, diagnostics, and laboratory automation demand; France supports immunology, oncology, and biomedical research; Italy and Spain are expanding hospital-based research, translational medicine, and clinical diagnostics; and Russia maintains capabilities in biomedical science despite supply-chain and geopolitical constraints. In Asia-Pacific, China is scaling biopharma and cell therapy research at speed, India is broadening access to advanced laboratory platforms and clinical research infrastructure, Japan is strong in regenerative medicine and high-quality instrumentation adoption, Australia supports robust clinical research and immunology programs, and South Korea is advancing biologics, diagnostics, and cell therapy manufacturing.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize automation, viability preservation, biosafety, and compliance-ready documentation because buyers increasingly evaluate cell sorting platforms on total workflow value rather than instrument specifications alone. Vendors that combine high-purity sorting with intuitive software, validated consumables, service uptime, operator training, and integration into LIMS or electronic laboratory records will be better positioned in regulated and translational settings.

Strategically, companies should build regional application support, develop AI-enabled analytics partnerships, and create offerings for both premium research centers and cost-sensitive emerging markets. Investment in closed-system sorting, sterile disposable cartridges, spectral data analysis, preventive maintenance, and training programs can help suppliers capture demand from cell therapy developers, CROs, hospitals, biomanufacturers, and academic laboratories.

Research Methodology

This executive summary is based on a structured secondary-research framework using publicly available and verifiable sources, including regulatory agency publications, clinical trial registries, government research funding information, peer-reviewed scientific literature, patent publications, standards guidance, and life science industry documentation. Market interpretation considers technology adoption across FACS, MACS, microfluidic sorting, imaging-enabled sorting, spectral cytometry, and label-free approaches.

The analysis triangulates demand indicators such as biomedical R&D intensity, cell and gene therapy activity, oncology and immunology research output, laboratory infrastructure, clinical trial concentration, public health priorities, and regional healthcare investment. Findings are presented to support strategic planning while avoiding unsupported market-size claims, market share statements, or unverified forecasts.

Conclusion

Cell sorting is becoming an essential infrastructure layer for precision biology, advanced therapeutics, and high-resolution cellular analysis. The market’s direction is defined by automation, AI-assisted analytics, sterile processing, viable cell recovery, and the need to translate complex cellular data into reliable research and clinical decisions.

Organizations that align product development, regional expansion, and service models with these trends can capture durable opportunities. The strongest competitive positions will come from combining scientific performance with workflow simplicity, regulatory awareness, data integrity, application support, and scalable service coverage across mature and emerging life science markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cell Sorting Market, by Product Offering
7.1. Introduction
7.2. Instruments
7.2.1. Cell Sorters
7.2.2. Microfluidic Sorting Systems
7.2.3. Sorting Modules And Upgrades
7.3. Reagents And Kits
7.3.1. Antibodies
7.3.2. Magnetic Beads
7.3.3. Buffers And Media
7.3.4. Viability Dyes And Stains
7.4. Consumables
7.5. Software
7.6. Services
7.6.1. Contract Cell Sorting
7.6.2. Maintenance And Support
7.6.3. Training And Method Development
8. Cell Sorting Market, by Sorting Technology
8.1. Introduction
8.2. Acoustic Cell Sorting
8.3. Fluorescence Activated Cell Sorting
8.4. Imaging Cell Sorting
8.5. Magnetic Activated Cell Sorting
8.5.1. Column-Based
8.5.2. Column-Free
8.6. Microfluidic Cell Sorting
8.7. Specialty Sorting
8.7.1. Laser Capture Microdissection
8.7.2. Raman-Activated Sorting
9. Cell Sorting Market, by Sample Source
9.1. Introduction
9.2. Blood
9.2.1. Whole Blood
9.2.2. Peripheral Blood Mononuclear Cells (PBMCs)
9.3. Bone Marrow
9.4. Solid Tissue
9.4.1. Tumor Tissue
9.4.2. Normal Tissue
9.5. Cell Culture
9.5.1. Primary Cells
9.5.2. Cell Lines
9.5.3. Organoids And Spheroids
9.6. Microbial Samples
9.6.1. Bacteria
9.6.2. Yeast And Fungi
10. Cell Sorting Market, by Application Area
10.1. Introduction
10.2. Life Science Research
10.2.1. Immunology
10.2.2. Oncology
10.2.3. Stem Cell Biology
10.2.4. Neuroscience
10.3. Clinical Diagnostics
10.3.1. Immunophenotyping
10.3.2. Hematologic Malignancies
10.3.3. Immune Monitoring
10.4. Cell Therapy And Regenerative Medicine
10.5. Drug Discovery
10.5.1. Target Identification And Validation
10.5.2. Screening And Lead Optimization
10.6. Single-Cell Omics
11. Cell Sorting Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Pharmaceutical & Biotechnology Companies
11.4. Contract Research Organizations
11.5. Hospitals & Clinics
12. Cell Sorting Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Africa
12.5. Middle East
12.6. Latin America
13. Cell Sorting Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Cell Sorting Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. France
14.8. Australia
14.9. South Korea
14.10. Italy
14.11. Russia
14.12. Canada
14.13. Spain
14.14. Brazil
14.15. Mexico
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Becton, Dickinson, and Company
16.2. Danaher Corporation
16.3. Bio-Rad Laboratories, Inc.
16.4. Thermo Fisher Scientific Inc.
16.5. Bio-Techne Corporation
16.6. Sino Biological, Inc.
16.7. Cytonome/St, LLC by STgenetics group
16.8. RayBiotech Life, Inc.
16.9. Menarini Silicon Biosystems SpA
16.10. Cytek Biosciences, Inc.
16.11. XIAMEN TOB NEW ENERGY TECHNOLOGY Co., LTD
16.12. Sony Biotechnology Inc.
16.13. Akadeum Life Sciences, Inc.
16.14. Miltenyi Biotec B.V. & Co. KG
16.15. NanoCellect Biomedical
16.16. On-Chip Biotechnologies Co., Ltd.
16.17. Sepmag Systems, SL
16.18. Sphere Fluidics Limited
16.19. Sysmex Partec GmbH
16.20. uFluidix LLC
16.21. Union Biometrica, Inc.
List of Figures
FIGURE 1. GLOBAL CELL SORTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CELL SORTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CELL SORTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CELL SORTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CELL SORTING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CELL SORTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CELL SORTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CELL SORTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CELL SORTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CELL SORTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CELL SORTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CELL SORTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CELL SORTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CELL SORTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL CELL SORTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CELL SORTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CELL SORTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CELL SORTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CELL SORTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CELL SORTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MICROFLUIDIC SORTING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MICROFLUIDIC SORTING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MICROFLUIDIC SORTING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SORTING MODULES AND UPGRADES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SORTING MODULES AND UPGRADES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SORTING MODULES AND UPGRADES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL REAGENTS AND KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL REAGENTS AND KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL REAGENTS AND KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ANTIBODIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ANTIBODIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MAGNETIC BEADS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MAGNETIC BEADS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MAGNETIC BEADS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL BUFFERS AND MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL BUFFERS AND MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL BUFFERS AND MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL VIABILITY DYES AND STAINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL VIABILITY DYES AND STAINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL VIABILITY DYES AND STAINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CONTRACT CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CONTRACT CELL SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CONTRACT CELL SORTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL MAINTENANCE AND SUPPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL MAINTENANCE AND SUPPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL MAINTENANCE AND SUPPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL TRAINING AND METHOD DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL TRAINING AND METHOD DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL TRAINING AND METHOD DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL ACOUSTIC CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL ACOUSTIC CELL SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ACOUSTIC CELL SORTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL FLUORESCENCE ACTIVATED CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL FLUORESCENCE ACTIVATED CELL SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL FLUORESCENCE ACTIVATED CELL SORTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL IMAGING CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL IMAGING CELL SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL IMAGING CELL SORTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL MAGNETIC ACTIVATED CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL MAGNETIC ACTIVATED CELL SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL MAGNETIC ACTIVATED CELL SORTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL COLUMN-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL COLUMN-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL COLUMN-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL COLUMN-FREE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL COLUMN-FREE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL COLUMN-FREE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL MICROFLUIDIC CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL MICROFLUIDIC CELL SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL MICROFLUIDIC CELL SORTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SPECIALTY SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SPECIALTY SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SPECIALTY SORTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL LASER CAPTURE MICRODISSECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL LASER CAPTURE MICRODISSECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL LASER CAPTURE MICRODISSECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL RAMAN-ACTIVATED SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL RAMAN-ACTIVATED SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL RAMAN-ACTIVATED SORTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL WHOLE BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL WHOLE BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL WHOLE BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL BONE MARROW MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL BONE MARROW MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL BONE MARROW MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL SOLID TISSUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL SOLID TISSUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL SOLID TISSUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL TUMOR TISSUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL TUMOR TISSUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL TUMOR TISSUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL NORMAL TISSUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL NORMAL TISSUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL NORMAL TISSUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL PRIMARY CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL PRIMARY CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL CELL LINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL CELL LINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL CELL LINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ORGANOIDS AND SPHEROIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ORGANOIDS AND SPHEROIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL ORGANOIDS AND SPHEROIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL MICROBIAL SAMPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL MICROBIAL SAMPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL MICROBIAL SAMPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL BACTERIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL BACTERIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL BACTERIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL YEAST AND FUNGI MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL YEAST AND FUNGI MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL YEAST AND FUNGI MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL LIFE SCIENCE RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL LIFE SCIENCE RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL LIFE SCIENCE RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL IMMUNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL IMMUNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL STEM CELL BIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL STEM CELL BIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL STEM CELL BIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL NEUROSCIENCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL NEUROSCIENCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL NEUROSCIENCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL IMMUNOPHENOTYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL IMMUNOPHENOTYPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL IMMUNOPHENOTYPING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL IMMUNE MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL IMMUNE MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL IMMUNE MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL CELL THERAPY AND REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL CELL THERAPY AND REGENERATIVE MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL CELL THERAPY AND REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL TARGET IDENTIFICATION AND VALIDATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL TARGET IDENTIFICATION AND VALIDATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL TARGET IDENTIFICATION AND VALIDATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL SCREENING AND LEAD OPTIMIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL SCREENING AND LEAD OPTIMIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL SCREENING AND LEAD OPTIMIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL SINGLE-CELL OMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL SINGLE-CELL OMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL SINGLE-CELL OMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL CELL SORTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 176. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 177. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 178. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 179. GLOBAL CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2017-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2017-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2017-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2017-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2017-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2017-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2017-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. EUROPE CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 199. EUROPE CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2017-2032 (USD MILLION)
TABLE 200. EUROPE CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 201. EUROPE CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2017-2032 (USD MILLION)
TABLE 202. EUROPE CELL SORTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 203. EUROPE CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 204. EUROPE CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 205. EUROPE CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2017-2032 (USD MILLION)
TABLE 206. EUROPE CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2017-2032 (USD MILLION)
TABLE 207. EUROPE CELL SORTING MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 208. EUROPE CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2017-2032 (USD MILLION)
TABLE 209. EUROPE CELL SORTING MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 210. EUROPE CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2017-2032 (USD MILLION)
TABLE 211. EUROPE CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 212. EUROPE CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2017-2032 (USD MILLION)
TABLE 213. EUROPE CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 214. EUROPE CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 215. EUROPE CELL SORTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 216. NORTH AMERICA CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 217. NORTH AMERICA CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2017-2032 (USD MILLION)
TABLE 218. NORTH AMERICA CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 219. NORTH AMERICA CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2017-2032 (USD MILLION)
TABLE 220. NORTH AMERICA CELL SORTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 221. NORTH AMERICA CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 222. NORTH AMERICA CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 223. NORTH AMERICA CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2017-2032 (USD MILLION)
TABLE 224. NORTH AMERICA CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2017-2032 (USD MILLION)
TABLE 225. NORTH AMERICA CELL SORTING MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 226. NORTH AMERICA CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2017-2032 (USD MILLION)
TABLE 227. NORTH AMERICA CELL SORTING MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 228. NORTH AMERICA CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2017-2032 (USD MILLION)
TABLE 229. NORTH AMERICA CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 230. NORTH AMERICA CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2017-2032 (USD MILLION)
TABLE 231. NORTH AMERICA CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 232. NORTH AMERICA CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 233. NORTH AMERICA CELL SORTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 234. AFRICA CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 235. AFRICA CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2017-2032 (USD MILLION)
TABLE 236. AFRICA CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 237. AFRICA CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2017-2032 (USD MILLION)
TABLE 238. AFRICA CELL SORTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 239. AFRICA CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 240. AFRICA CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 241. AFRICA CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2017-2032 (USD MILLION)
TABLE 242. AFRICA CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2017-2032 (USD MILLION)
TABLE 243. AFRICA CELL SORTING MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 244. AFRICA CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2017-2032 (USD MILLION)
TABLE 245. AFRICA CELL SORTING MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 246. AFRICA CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2017-2032 (USD MILLION)
TABLE 247. AFRICA CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 248. AFRICA CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2017-2032 (USD MILLION)
TABLE 249. AFRICA CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 250. AFRICA CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 251. AFRICA CELL SORTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 252. MIDDLE EAST CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 253. MIDDLE EAST CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2017-2032 (USD MILLION)
TABLE 254. MIDDLE EAST CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 255. MIDDLE EAST CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2017-2032 (USD MILLION)
TABLE 256. MIDDLE EAST CELL SORTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 257. MIDDLE EAST CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 258. MIDDLE EAST CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 259. MIDDLE EAST CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2017-2032 (USD MILLION)
TABLE 260. MIDDLE EAST CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2017-2032 (USD MILLION)
TABLE 261. MIDDLE EAST CELL SORTING MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 262. MIDDLE EAST CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2017-2032 (USD MILLION)
TABLE 263. MIDDLE EAST CELL SORTING MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 264. MIDDLE EAST CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2017-2032 (USD MILLION)
TABLE 265. MIDDLE EAST CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 266. MIDDLE EAST CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2017-2032 (USD MILLION)
TABLE 267. MIDDLE EAST CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 268. MIDDLE EAST CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 269. MIDDLE EAST CELL SORTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 270. LATIN AMERICA CELL SORTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 271. LATIN AMERICA CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2017-2032 (USD MILLION)
TABLE 272. LATIN AMERICA CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 273. LATIN AMERICA CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2017-2032 (USD MILLION)
TABLE 274. LATIN AMERICA CELL SORTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 275. LATIN AMERICA CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 276. LATIN AMERICA CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 277. LATIN AMERICA CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2017-2032 (USD MILLION)
TABLE 278. LATIN AMERICA CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2017-2032 (USD MILLION)
TABLE 279. LATIN AMERICA CELL SORTING MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 280. LATIN AMERICA CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2017-2032 (USD MILLION)
TABLE 281. LATIN AMERICA CELL SORTING MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 282. LATIN AMERICA CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2017-2032 (USD MILLION)
TABLE 283. LATIN AMERICA CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 284. LATIN AMERICA CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2017-2032 (USD MILLION)
TABLE 285. LATIN AMERICA CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 286. LATIN AMERICA CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 287. LATIN AMERICA CELL SORTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 288. GLOBAL CELL SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 289. NATO CELL SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 290. NATO CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2017-2032 (USD MILLION)
TABLE 291. NATO CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 292. NATO CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2017-2032 (USD MILLION)
TABLE 293. NATO CELL SORTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 294. NATO CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 295. NATO CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 296. NATO CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2017-2032 (USD MILLION)
TABLE 297. NATO CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2017-2032 (USD MILLION)
TABLE 298. NATO CELL SORTING MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 299. NATO CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2017-2032 (USD MILLION)
TABLE 300. NATO CELL SORTING MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 301. NATO CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2017-2032 (USD MILLION)
TABLE 302. NATO CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 303. NATO CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2017-2032 (USD MILLION)
TABLE 304. NATO CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 305. NATO CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 306. NATO CELL SORTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 307. G7 CELL SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 308. G7 CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2017-2032 (USD MILLION)
TABLE 309. G7 CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 310. G7 CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2017-2032 (USD MILLION)
TABLE 311. G7 CELL SORTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 312. G7 CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 313. G7 CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 314. G7 CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2017-2032 (USD MILLION)
TABLE 315. G7 CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2017-2032 (USD MILLION)
TABLE 316. G7 CELL SORTING MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 317. G7 CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2017-2032 (USD MILLION)
TABLE 318. G7 CELL SORTING MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 319. G7 CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2017-2032 (USD MILLION)
TABLE 320. G7 CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 321. G7 CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2017-2032 (USD MILLION)
TABLE 322. G7 CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 323. G7 CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 324. G7 CELL SORTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 325. BRICS CELL SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 326. BRICS CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2017-2032 (USD MILLION)
TABLE 327. BRICS CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 328. BRICS CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2017-2032 (USD MILLION)
TABLE 329. BRICS CELL SORTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 330. BRICS CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 331. BRICS CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 332. BRICS CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2017-2032 (USD MILLION)
TABLE 333. BRICS CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2017-2032 (USD MILLION)
TABLE 334. BRICS CELL SORTING MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 335. BRICS CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2017-2032 (USD MILLION)
TABLE 336. BRICS CELL SORTING MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 337. BRICS CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2017-2032 (USD MILLION)
TABLE 338. BRICS CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 339. BRICS CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2017-2032 (USD MILLION)
TABLE 340. BRICS CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 341. BRICS CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 342. BRICS CELL SORTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 343. EUROPEAN UNION CELL SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 344. EUROPEAN UNION CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2017-2032 (USD MILLION)
TABLE 345. EUROPEAN UNION CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 346. EUROPEAN UNION CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2017-2032 (USD MILLION)
TABLE 347. EUROPEAN UNION CELL SORTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 348. EUROPEAN UNION CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 349. EUROPEAN UNION CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 350. EUROPEAN UNION CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2017-2032 (USD MILLION)
TABLE 351. EUROPEAN UNION CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2017-2032 (USD MILLION)
TABLE 352. EUROPEAN UNION CELL SORTING MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 353. EUROPEAN UNION CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2017-2032 (USD MILLION)
TABLE 354. EUROPEAN UNION CELL SORTING MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 355. EUROPEAN UNION CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2017-2032 (USD MILLION)
TABLE 356. EUROPEAN UNION CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2017-2032 (USD MILLION)
TABLE 357. EUROPEAN UNION CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2017-2032 (USD MILLION)
TABLE 358. EUROPEAN UNION CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 359. EUROPEAN UNION CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 360. EUROPEAN UNION CELL SORTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 361. ASEAN CELL SORTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 362. ASEAN CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2017-2032 (USD MILLION)
TABLE 363. ASEAN CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 364. ASEAN CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2017-2032 (USD MILLION)
TABLE 365. ASEAN CELL SORTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 366. ASEAN CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 367. ASEAN CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2017-2032 (USD MILLION)
TABLE 368. ASEAN CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2017-2032 (USD MILLION)
TABLE 369. ASEAN CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2017-2032 (USD MILLION)
TABLE 370. ASEAN CELL SORTING MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 371. ASEAN CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2017-2032 (USD MILLION)
TABLE 372. ASEAN CELL SORTING MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 373. ASEAN CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2017-2032 (USD MILLION)
TABLE 374. ASEAN CELL SORTING MARKET SIZE, BY APPLICATION AREA,

Companies Mentioned

  • Becton, Dickinson, and Company
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Bio-Techne Corporation
  • Sino Biological, Inc.
  • Cytonome/St, LLC by STgenetics group
  • RayBiotech Life, Inc.
  • Menarini Silicon Biosystems SpA
  • Cytek Biosciences, Inc.
  • XIAMEN TOB NEW ENERGY TECHNOLOGY Co., LTD
  • Sony Biotechnology Inc.
  • Akadeum Life Sciences, Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • NanoCellect Biomedical
  • On-Chip Biotechnologies Co., Ltd.
  • Sepmag Systems, SL
  • Sphere Fluidics Limited
  • Sysmex Partec GmbH
  • uFluidix LLC
  • Union Biometrica, Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.85 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.07 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Replaceable Fluid Cell Sorting Machine Market - Global Forecast 2026-2032 - Product Image

Replaceable Fluid Cell Sorting Machine Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Cell Sorting - Global Strategic Business Report - Product Image

Cell Sorting - Global Strategic Business Report

  • Report
  • 252 Pages
  • Global
From
Cell Sorting Market Forecast to 2033 - Product Image

Cell Sorting Market Forecast to 2033

  • Report
  • 150 Pages
  • Global
From
Cell Sorting Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology, Product & Service, Application, Cell Type - Product Image

Cell Sorting Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology, Product & Service, Application, Cell Type

  • Report
  • 160 Pages
  • Global
From
Cancer Diagnostics Market - Global Forecast 2026-2032 - Product Image

Cancer Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From

About the Cell Sorting Market

Cell sorting is a process used in genomics to separate cells based on their physical and/or biochemical characteristics. It is used to isolate and purify specific cell populations for further analysis. Cell sorting can be used to study cell populations in a variety of ways, including cell cycle analysis, cell viability, and cell surface marker expression. It is also used to isolate rare cell populations, such as stem cells, for further study. Cell sorting is an important tool in genomics research, as it allows researchers to study cell populations in greater detail. It is also used in clinical applications, such as cancer diagnosis and treatment. There are a number of companies that offer cell sorting services and products. These include BD Biosciences, Miltenyi Biotec, Sysmex, and Thermo Fisher Scientific. Additionally, there are a number of smaller companies that specialize in cell sorting, such as Cell Sorting Technologies, Cell Sorting Solutions, and Cell Sorting Systems. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.